University of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Chicago sits in the top decile of US sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count).
University of Chicago: 796 sponsored US clinical trials, 158 recruiting.
University of Chicago sponsors 796 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 451 completed. 67 of these trials are in Phase 3-4 (later-stage) and 293 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 11 trials.
Top-decile sponsor footprint
University of Chicago ranks in the top decile of sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
451 of 562 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
796 total, page 15 of 16
Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents
NCT00183586
Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry
NCT00147940
Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry
NCT00147888
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
NCT00203905
Prostate Cancer Utilities and Cost-Effectiveness Analysis
NCT00203918
The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
NCT00228345
Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
NCT00181285
C.A.T.C.H.-I.T.Competent Adulthood Transition With Cognitive, Humanistic and Interpersonal Teaching
NCT00152529
Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma
NCT00203866
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
NCT00203996
Sildenafil and Pulmonary Artery Pressure
NCT00145938
The Effectiveness of Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk
NCT00204282
Nesiritide in Chronic Heart Failure
NCT00145873
A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder
NCT00078754
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
NCT00943293
Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma
NCT00203892
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
NCT01693718
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer
NCT01187472
Physical Therapy for Systemic Lupus Erythematosus (SLE)
NCT00152555
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
NCT00053222
rhPTH Therapy for Low Turnover Bone Fragility
NCT00145886
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer
NCT01185171
Tumor Gene Expression in Women With Ovarian Cancer
NCT00817479
Extended Work Schedules, Sleep Loss and Health
NCT00989534
Transfer to Another Health Care Facility Following Critical Illness
NCT00484445
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
NCT00774046
Drug Treatment for Pathologic Gambling Disorder
NCT00053677
Assessing CPR Quality During In-Hospital Cardiac Arrest
NCT00228293
Measurement of Jugular Venous Pulse in Critically Ill Patients.
NCT00303355
International Adoption and Stress Response Study
NCT00203944
A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma
NCT01185158
Comparison of Sirolimus and Azathioprine in Lung Transplantation
NCT00321906
Do Patients With Colorectal Cancer Understand That Their Family is at Risk?
NCT00145860
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
NCT00203879
A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED
NCT00127400
Childhood Obesity: Variations in Management
NCT00160914
Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
NCT00025389
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00015977
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
NCT00683046
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT00026377
PS-341 in Treating Patients With Metastatic Kidney Cancer
NCT00025376
Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
NCT00026299
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00022477
A Multicenter Trial of Academic Hospitalists
NCT00204048
Texture Analysis for Postmenopausal Osteoporosis
NCT00145977
The Effectiveness of Car Seat Checks at Routine Pediatric Visits
NCT00152568
Family Therapy for Adolescent Bulimia Nervosa
NCT00518843
ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
NCT00015964
Doula Support for Young Mothers: A Randomized Trial
NCT01925664
O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
NCT00005066
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 137 |
| Phase 2 | 156 |
| Phase 3 | 14 |
| Phase 4 | 53 |
Therapeutic Areas
What is open in the University of Chicago pipeline
158 recruiting of 796 indexed (20% open); 451 completed (57%).
Phase mix: 67 late (III/IV) vs 293 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Chicago: open-pipeline peers nationwide
Peers matched on 796 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 796 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
- University of Utah · 818 trials · 17% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this University of Chicago page
796 registered trials is a research-attention snapshot, not an endorsement of University of Chicago or any single study.
- 158 of University of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Chicago pipeline card: 796 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.